PURPOSE: As a transcriptional repressor of E-cadherin, Snail has predominantly been associated with epithelial-mesenchymal transition, invasion, and metastasis. However, other important Snail-dependent malignant phenotypes have not been fully explored. Here, we investigate the contributions of Snail to the progression of non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN: Immunohistochemistry was done to quantify and localize Snail in human lung cancer tissues, and tissue microarray analysis was used to correlate these findings with survival. NSCLC cell lines gene-modified to stably overexpress Snail were evaluated in vivo in two severe combined immunodeficiency murine tumor models. Differential gene expression between Snail-overexpressing and control cell lines was evaluated using gene expression microarray analysis. RESULTS: Snail is upregulated in human NSCLC tissue, and high levels of Snail expression correlate with decreased survival (P < 0.026). In a heterotopic model, mice bearing Snail-overexpressing tumors developed increased primary tumor burden (P = 0.008). In an orthotopic model, mice bearing Snail-overexpressing tumors also showed a trend toward increased metastases. In addition, Snail overexpression led to increased angiogenesis in primary tumors as measured by MECA-32 (P < 0.05) positivity and CXCL8 (P = 0.002) and CXCL5 (P = 0.0003) concentrations in tumor homogenates. Demonstrating the importance of these proangiogenic chemokines, the Snail-mediated increase in tumor burden was abrogated with CXCR2 blockade. Gene expression analysis also revealed Snail-associated differential gene expression with the potential to affect angiogenesis and diverse aspects of lung cancer progression. CONCLUSION: Snail upregulation plays a role in human NSCLC by promoting tumor progression mediated by CXCR2 ligands.
PURPOSE: As a transcriptional repressor of E-cadherin, Snail has predominantly been associated with epithelial-mesenchymal transition, invasion, and metastasis. However, other important Snail-dependent malignant phenotypes have not been fully explored. Here, we investigate the contributions of Snail to the progression of non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN: Immunohistochemistry was done to quantify and localize Snail in humanlung cancer tissues, and tissue microarray analysis was used to correlate these findings with survival. NSCLC cell lines gene-modified to stably overexpress Snail were evaluated in vivo in two severe combined immunodeficiency murine tumor models. Differential gene expression between Snail-overexpressing and control cell lines was evaluated using gene expression microarray analysis. RESULTS:Snail is upregulated in humanNSCLC tissue, and high levels of Snail expression correlate with decreased survival (P < 0.026). In a heterotopic model, mice bearing Snail-overexpressing tumors developed increased primary tumor burden (P = 0.008). In an orthotopic model, mice bearing Snail-overexpressing tumors also showed a trend toward increased metastases. In addition, Snail overexpression led to increased angiogenesis in primary tumors as measured by MECA-32 (P < 0.05) positivity and CXCL8 (P = 0.002) and CXCL5 (P = 0.0003) concentrations in tumor homogenates. Demonstrating the importance of these proangiogenic chemokines, the Snail-mediated increase in tumor burden was abrogated with CXCR2 blockade. Gene expression analysis also revealed Snail-associated differential gene expression with the potential to affect angiogenesis and diverse aspects of lung cancer progression. CONCLUSION:Snail upregulation plays a role in humanNSCLC by promoting tumor progression mediated by CXCR2 ligands.
Authors: C Francí; M Takkunen; N Dave; F Alameda; S Gómez; R Rodríguez; M Escrivà; B Montserrat-Sentís; T Baró; M Garrido; F Bonilla; I Virtanen; A García de Herreros Journal: Oncogene Date: 2006-03-27 Impact factor: 9.867
Authors: Samir E Witta; Robert M Gemmill; Fred R Hirsch; Christopher D Coldren; Karla Hedman; Larisa Ravdel; Barbara Helfrich; Rafal Dziadziuszko; Daniel C Chan; Michio Sugita; Zeng Chan; Anna Baron; Wilbur Franklin; Harry A Drabkin; Luc Girard; Adi F Gazdar; John D Minna; Paul A Bunn Journal: Cancer Res Date: 2006-01-15 Impact factor: 12.701
Authors: Mariam Dohadwala; Seok-Chul Yang; Jie Luo; Sherven Sharma; Raj K Batra; Min Huang; Ying Lin; Lee Goodglick; Kostyantyn Krysan; Michael C Fishbein; Longsheng Hong; Chi Lai; Robert B Cameron; Robert M Gemmill; Harry A Drabkin; Steven M Dubinett Journal: Cancer Res Date: 2006-05-15 Impact factor: 12.701
Authors: Christophe Côme; Fabrice Magnino; Frédéric Bibeau; Pascal De Santa Barbara; Karl Friedrich Becker; Charles Theillet; Pierre Savagner Journal: Clin Cancer Res Date: 2006-09-15 Impact factor: 12.531
Authors: Marie Wislez; Nobukazu Fujimoto; Julie G Izzo; Amy E Hanna; Dianna D Cody; Robert R Langley; Hongli Tang; Marie D Burdick; Mitsuo Sato; John D Minna; Li Mao; Ignacio Wistuba; Robert M Strieter; Jonathan M Kurie Journal: Cancer Res Date: 2006-04-15 Impact factor: 12.701
Authors: Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma Journal: Immunotherapy Date: 2012-03 Impact factor: 4.196
Authors: Gong Yang; Daniel G Rosen; Guangzhi Liu; Fan Yang; Xiaoqing Guo; Xue Xiao; Fengxia Xue; Imelda Mercado-Uribe; Jiaoti Huang; Sue-Hwa Lin; Gordon B Mills; Jinsong Liu Journal: Clin Cancer Res Date: 2010-05-26 Impact factor: 12.531
Authors: Brigitte N Gomperts; Avrum Spira; Pierre P Massion; Tonya C Walser; Ignacio I Wistuba; John D Minna; Steven M Dubinett Journal: Semin Respir Crit Care Med Date: 2011-04-15 Impact factor: 3.119
Authors: Chayanin Kiratipaiboon; Todd A Stueckle; Rajib Ghosh; Liying W Rojanasakul; Yi Charlie Chen; Cerasela Zoica Dinu; Yon Rojanasakul Journal: Environ Sci Nano Date: 2019-05-24